|
Volumn 84, Issue 2, 1999, Pages 191-192
|
Recombinant human tissue plasminogen activator without heparin is effective in the treatment of hepatic veno-occlusive disease [8]
a a a a a a |
Author keywords
Bleeding; Bone marrow transplant; Hepatic veno occlusive disease; Recombinant human tissue plasminogen activator
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALTEPLASE;
ASPARTATE AMINOTRANSFERASE;
BILIRUBIN;
BUSULFAN;
CYCLOPHOSPHAMIDE;
FIBRINOLYTIC AGENT;
HEPARIN;
MELPHALAN;
ADULT;
BLEEDING;
BONE MARROW TRANSPLANTATION;
CLINICAL ARTICLE;
DRUG EFFICACY;
FEMALE;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LETTER;
MALE;
VEIN OCCLUSION;
ADULT;
FEMALE;
FIBRINOLYTIC AGENTS;
HEPARIN;
HEPATIC VENO-OCCLUSIVE DISEASE;
HUMANS;
MALE;
MIDDLE AGED;
RECOMBINANT PROTEINS;
TISSUE PLASMINOGEN ACTIVATOR;
TREATMENT OUTCOME;
|
EID: 0032832535
PISSN: 03906078
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (2)
|
References (9)
|